IOVA icon

Iovance Biotherapeutics

257 hedge funds and large institutions have $3.88B invested in Iovance Biotherapeutics in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 92 increasing their positions, 66 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

4% more capital invested

Capital invested by funds: $3.73B → $3.88B (+$148M)

2.21% less ownership

Funds ownership: 98.46%96.25% (-2.2%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$69.1M
Puts
$23.7M
Net Calls
Net Calls Change

Top Sellers

1 -$47.6M
2 -$45.1M
3 -$30.9M
4
State Street
State Street
Massachusetts
-$27.3M
5
MP
Mangrove Partners
Connecticut
-$21.9M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$336M
2
$324M
3
$284M
4
$266M
5
$203M
6
$200M
7
$182M
8
$179M
9
$116M
10
$102M
11
$93.4M
12
$89.7M
13
$89.5M
14
$82.1M
15
$75.8M
16
$75.4M
17
$62M
18
$50.5M
19
$48.8M
20
$44M
21
$39.8M
22
$39.3M
23
$39M
24
$37.7M
25
$36M